These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9712735

  • 1. Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor protein.
    Ceha HM, Nasser I, Medema RH, Slebos RJ.
    Biochem Biophys Res Commun; 1998 Aug 19; 249(2):550-5. PubMed ID: 9712735
    [Abstract] [Full Text] [Related]

  • 2. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.
    Becker TM, Rizos H, Kefford RF, Mann GJ.
    Clin Cancer Res; 2001 Oct 19; 7(10):3282-8. PubMed ID: 11595726
    [Abstract] [Full Text] [Related]

  • 3. Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene.
    Tsao H, Benoit E, Sober AJ, Thiele C, Haluska FG.
    Cancer Res; 1998 Jan 01; 58(1):109-13. PubMed ID: 9426066
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R, Laín S, Ball KL, Lane DP.
    Oncogene; 1998 Feb 05; 16(5):587-96. PubMed ID: 9482104
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of p16INK4a and its interaction with CDK4.
    Yang R, Serrano M, Slater J, Leung E, Koeffler HP.
    Biochem Biophys Res Commun; 1996 Jan 05; 218(1):254-9. PubMed ID: 8573142
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J.
    Cancer Res; 2000 Dec 15; 60(24):6864-7. PubMed ID: 11156381
    [Abstract] [Full Text] [Related]

  • 15. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
    Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT.
    Br J Cancer; 1999 Apr 15; 80(1-2):295-300. PubMed ID: 10390011
    [Abstract] [Full Text] [Related]

  • 16. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
    Li J, Melvin WS, Tsai MD, Muscarella P.
    Biochemistry; 2004 Apr 13; 43(14):4394-9. PubMed ID: 15065884
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. p16 proteins from melanoma-prone families are deficient in binding to Cdk4.
    Reymond A, Brent R.
    Oncogene; 1995 Sep 21; 11(6):1173-8. PubMed ID: 7566978
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.